Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0000899243-20-027447

Options or other derivatives

  • Director acquired 742,788 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
COHEN MARC A Director 2020-10-01 Grant or award · Stock Option (Right to Buy) +725,002 725,002 D
COHEN MARC A Director 2020-10-01 Grant or award · Stock Option (Right to Buy) +17,786 17,786 D
Loading xslF345X03/doc4.xml…